February 13, 2014
Kaken Pharmaceutical announced on February 10 that it entered into a technology licensing agreement on the same day with Valeant Pharmaceuticals International of Canada to grant the rights to use Kaken’s drug container technology and relevant data for its onychomycosis...read more